Gewählte Publikation:
Scherr, D; Brunner, G; Kaufmann, P; Lercher, P; Lueger, A; Rotman, B; Smolle, KH; Stark, G; Klein, W; Krejs, GJ.
Aborted sudden death in a patient with a structurally normal heart: the Brugada syndrome.
Intensive Care Med. 2002; 28(6):789-792
Doi: 10.1007/s00134-002-1300-z
(- Case Report)
Web of Science
PubMed
FullText
FullText_MUG
Google Scholar
- Führende Autor*innen der Med Uni Graz
-
Scherr Daniel
- Co-Autor*innen der Med Uni Graz
-
Brunner Gernot
-
Klein Werner
-
Krejs Günter Josef
-
Lercher Peter
-
Lueger Andreas
-
Rotman Brigitte
-
Smolle Karl-Heinz
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- We report a 37-year-old man with documented aborted sudden death. After resuscitation, the patient showed no structural heart disease but the ECG showed a right bundle-branch block with a descending ST segment elevation in leads V(1) and V(2). After transient normalization of the ECG, the administration of ajmaline led to spontaneous development of the distinct descending ST segment elevation in the right precordial leads and therefore to the diagnosis of Brugada syndrome. The incidence of sudden cardiac death among these patients is high. The only treatment is an implantable cardioverter-defibrillator (ICD). The Brugada syndrome should therefore be borne in mind in the differential diagnosis of sudden death.
- Find related publications in this database (using NLM MeSH Indexing)
-
Adult -
-
Ajmaline - diagnostic use
-
Anti-Arrhythmia Agents - diagnostic use
-
Death, Sudden, Cardiac - prevention and control
-
Defibrillators, Implantable -
-
Diagnosis, Differential -
-
Electrocardiography -
-
Humans -
-
Male -
-
Myocardial Infarction - diagnosis Myocardial Infarction - physiopathology Myocardial Infarction - therapy
-
Resuscitation -
- Find related publications in this database (Keywords)
-
ajmaline
-
arrhythmia
-
Brugada Syndrome
-
ventricular fibrillation
-
ST segment elevation
-
sudden death